Divis Laboratories Stock Price - ₹9,144.50 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Divis Laboratories Stock Price - ₹9,144.50 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q4 FY15	Q1 FY19	Q2 FY19	Q3 FY19	Q4 FY19	Q1 FY20	Q2 FY20	Q3 FY20	Q4 FY20	Q1 FY21	Q2 FY21	Q3 FY21	Q4 FY21	Q1 FY22	Q2 FY22	Q3 FY22	Q4 FY22	Q1 FY23	Q2 FY23	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Sales	820.7	995.24	1,323.93	1,359.96	1,267.13	1,162.88	1,445.57	1,396.26	1,389.71	1,730.47	1,749.3	1,701.44	1,788.19	1,960.64	1,987.51	2,493.24	2,518.44	2,255	1,855	1,708	1,951	1,778	1,909	1,855	2,303	2,118	2,338	2,319	2,585	2,410	2,715	2,604	2,831	3,080
Expenses	501.42	642.77	802.44	827.09	850.73	775.74	955.01	902.36	945.26	1,030.39	1,008.16	1,010.23	1,071.93	1,108.59	1,169.44	1,396.06	1,414.02	1,406	1,234	1,299	1,464	1,274	1,430	1,366	1,572	1,496	1,622	1,576	1,699	1,681	1,827	1,714	1,897	1,825
EBITDA	319.28	352.47	521.49	532.87	416.4	387.14	490.56	493.9	444.45	700.08	741.14	691.21	716.26	852.05	818.07	1,097.18	1,104.42	849	621	409	487	504	479	489	731	622	716	743	886	729	888	890	934	1,255
Depreciation	44.65	41.62	42.41	42.5	42.37	43.83	45.93	46.7	49.78	56.2	61.13	68.18	70.08	73.26	77.35	79.91	80.99	85	86	87	87	93	95	95	95	97	99	99	107	112	113	118	120	133
EBIT	274.63	310.85	479.08	490.37	374.03	343.31	444.63	447.2	394.67	643.88	680.01	623.03	646.18	778.79	740.72	1,017.27	1,023.43	764	535	322	400	411	384	394	636	525	617	644	779	617	775	772	814	1,122
Interest	0.59	0.64	0.24	2.52	0.1	0.32	3.79	1.55	0.44	0.23	0.16	0.27	0.21	0.28	0.21	0.23	0.08	0	0	0	0	0	1	0	2	0	1	0	1	3	8	6	6	6
Profit Before Tax	274.04	310.21	478.84	487.85	373.93	342.99	440.84	445.65	394.23	643.65	679.85	622.76	645.97	778.51	740.51	1,017.04	1,023.35	764	535	322	400	411	383	394	634	525	616	644	778	614	767	766	808	1,116
Net Profit	231.47	267.67	403.72	389.38	291.97	272.44	356.78	359.09	388.23	492.06	519.59	470.62	502.02	557.11	606.46	902.24	894.64	702	493	306	321	356	348	358	538	430	510	589	662	545	689	583	751	902
EPS	17.4	10.08	15.21	14.67	11	10.26	13.44	13.53	14.62	18.54	19.57	17.73	18.91	20.99	22.84	33.99	33.7	26.44	18.6	11.56	12.09	13.41	13.11	13.5	20.25	16.2	19.2	22.2	24.93	20.49	25.97	21.98	28.31	33.95

Cashflow

₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Operating Cash Flow	826.33	1,037.86	1,150.37	775.86	954.3	1,215.94	1,946.93	1,911.8	2,459.73	1,261	1,653	2,738
Investing Cash Flow	-520.84	-406.41	-1,139.6	-478.3	-685.4	-83.47	75.13	-2,194.92	-2,707.62	-269	-804	-2,219
Financing Cash Flow	-302.95	-631.12	2.38	-314.16	-245.94	-1,091.42	-34.89	-532.44	-797.17	-799	-799	-804
Net Cash Flow	2.54	0.33	13.15	-16.6	22.96	41.05	1,987.17	-815.56	-1,045.06	193	50	-285

Balance Sheet

Annual

₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Equity / Shareholders' Funds	3,495.36	4,293.31	5,357.39	5,924.8	6,957.15	7,309.92	9,294.61	11,728.2	12,767.1	13,571	14,969	16,761
Total Liabilities	916.02	608.81	801.14	861.05	1,081.1	1,225.78	1,479.46	1,646.53	1,671.68	1,899	1,963	3,272
Total Assets	4,411.38	4,902.12	6,158.53	6,785.85	8,038.25	8,535.7	10,774.1	13,374.7	14,438.8	15,470	16,932	20,033

Shareholding

₹2.4L CrMarket Cap

Promoter & promoter group (51.88%)

DIIs (19.17%)

FIIs (20.38%)

Public & others (8.58%)